Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation

New England Journal of Medicine

Volumn 374, Issue 23, 2016, Pages 2235-2245

  Kuck, Karl Heinz ^a   Brugada, Josep ^e   Fürnkranz, Alexander ^b   Metzner, Andreas ^a   Ouyang, Feifan ^a   Chun, K R Julian ^b   Elvan, Arif ^f   Arentz, Thomas ^c   Bestehorn, Kurt ^d   Pocock, Stuart J ^g   Albenque, Jean Paul ^h   Tondo, Claudio ⁱ  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY OF BARCELONA   (Spain)

^f ISALA HOSPITAL   (Netherlands)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h CLINIQUE PASTEUR   (France)

ⁱ UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ABLATION CATHETER; ADULT; AGED; ARTICLE; CATHETER ABLATION; CATHETER COMPLICATION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CRYOBALLOON ABLATION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART ATRIUM FLUTTER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NERVE INJURY; PARALLEL DESIGN; PAROXYSMAL ATRIAL FIBRILLATION; PATIENT SAFETY; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUPRAVENTRICULAR TACHYCARDIA; THERAPY EFFECT; TREATMENT DURATION; TREATMENT FAILURE; ATRIAL FIBRILLATION; CLINICAL TRIAL; COMPARATIVE STUDY; CRYOSURGERY; DEVICES; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; POSTOPERATIVE COMPLICATION; PROCEDURES; REOPERATION; SINGLE BLIND PROCEDURE;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; CRYOSURGERY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REOPERATION; SINGLE-BLIND METHOD;

EID: 84969715725     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1602014     Document Type: Article

References (19)

1. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation: developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS): endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 2012;9:632-696.e21.
2. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
3. Verma A, Jiang C, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 2015;372:1812-22.
4. Fürnkranz A, Brugada J, Albenque JP, et al. Rationale and design of FIRE AND ICE: a multicenter randomized trial comparing efficacy and safety of pulmonary vein isolation using a cryoballoon versus radiofrequency ablation with 3D-reconstruction. J Cardiovasc Electrophysiol 2014;25:1314-20.
5. Luik A, Radzewitz A, Kieser M, et al. Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: the prospective, randomized, controlled, noninferiority FreezeAF Study. Circulation 2015;132:1311-9.
6. Wasserlauf J, Pelchovitz DJ, Rhyner J, et al. Cryoballoon versus radiofrequency catheter ablation for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2015;38:483-9.
7. Aryana A, Singh SM, Kowalski M, et al. Acute and long-term outcomes of catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: a multicenter experience. J Cardiovasc Electrophysiol 2015;26:832-9.
8. Hunter RJ, Baker V, Finlay MC, et al. Point-by-point radiofrequency ablation versus the cryoballoon or a novel combined approach: a randomized trial comparing 3 methods of pulmonary vein isolation for paroxysmal atrial fibrillation (the Cryo Versus RF Trial). J Cardiovasc Electrophysiol 2015;26:1307-14.
9. Jourda F, Providencia R, Marijon E, et al. Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation. Europace 2015;17:225-31.
10. Squara F, Zhao A, Marijon E, et al. Comparison between radiofrequency with contact force-sensing and second-generation cryoballoon for paroxysmal atrial fibrillation catheter ablation: a multicentre European evaluation. Europace 2015;17:718-24.
11. Jung S-H, Kang SJ, McCall LM, Blumenstein B. Sample size computation for two-sample noninferiority log-rank test. J Biopharm Stat 2005;15:969-79.
12. Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 2013;61:1713-23.
13. Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010;303:333-40.
14. Kuck KH, Hoffmann BA, Ernst S, et al. Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial. Circ Arrhythm Electrophysiol 2016;9(1):e003337.
15. Natale A, Reddy VY, Monir G, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol 2014;64:647-56.
16. Kautzner J, Neuzil P, Lambert H, et al. EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 2015;17:1229-35.
17. Reddy VY, Sediva L, Petru J, et al. Durability of pulmonary vein isolation with cryoballoon ablation: results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study. J Cardiovasc Electrophysiol 2015;26:493-500.
18. Kenigsberg DN, Martin N, Lim HW, Kowalski M, Ellenbogen KA. Quantification of the cryoablation zone demarcated by pre- and postprocedural electroanatomic mapping in patients with atrial fibrillation using the 28-mm second-generation cryoballoon. Heart Rhythm 2015;12:283-90.
19. Yorgun H, Aytemir K, Canpolat U, Şahiner L, Kaya EB, Oto A. Additional benefit of cryoballoon-based atrial fibrillation ablation beyond pulmonary vein isolation: modification of ganglionated plexi. Europace 2014;16:645-51.